Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dummer

Showing results (191-200 of 328) with videos related to

Pageof 33
Sort By:
Dermatology (Basel, Switzerland)|January 1, 1994
Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gammaR Dummer, S Sigg-Zemann, K Kalthof, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivoA Davis-Daneshfar, R Böni, P von Wussow, et al.
British Journal of Cancer|July 4, 1998
Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10R Dummer, F Y Yue, J Pavlovic, et al.
Archives of Dermatological Research|August 1, 1996
Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVAG P Rajan, B Seifert, O Prümmer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2017
Vismodegib for recurrent locally destructive basal cell carcinoma in a renal transplant patientP Koelblinger, R Dummer, M Laimer, et al.
International Journal of Cancer|March 10, 2001
TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosisJ Kamarashev, S Ferrone, B Seifert, et al.
The British Journal of Dermatology|June 1, 1993
Evidence for cell-mediated immune mechanisms in the pathology of pemphigusD Zillikens, A Ambach, A Zentner, et al.
The Journal of Investigative Dermatology|January 5, 2000
CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomasB Laetsch, A C Häffner, U Döbbeling, et al.
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
Onkologie|May 13, 2004
Survival and prognostic factors in patients with brain metastases from malignant melanomaS Meier, B G Baumert, T Maier, et al.
Pageof 33

Showing results (191-200 of 328) with videos related to

Sort By:
Pageof 33
Dermatology (Basel, Switzerland)|January 1, 1994
Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gammaR Dummer, S Sigg-Zemann, K Kalthof, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivoA Davis-Daneshfar, R Böni, P von Wussow, et al.
British Journal of Cancer|July 4, 1998
Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10R Dummer, F Y Yue, J Pavlovic, et al.
Archives of Dermatological Research|August 1, 1996
Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVAG P Rajan, B Seifert, O Prümmer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2017
Vismodegib for recurrent locally destructive basal cell carcinoma in a renal transplant patientP Koelblinger, R Dummer, M Laimer, et al.
International Journal of Cancer|March 10, 2001
TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosisJ Kamarashev, S Ferrone, B Seifert, et al.
The British Journal of Dermatology|June 1, 1993
Evidence for cell-mediated immune mechanisms in the pathology of pemphigusD Zillikens, A Ambach, A Zentner, et al.
The Journal of Investigative Dermatology|January 5, 2000
CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomasB Laetsch, A C Häffner, U Döbbeling, et al.
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
Onkologie|May 13, 2004
Survival and prognostic factors in patients with brain metastases from malignant melanomaS Meier, B G Baumert, T Maier, et al.
Pageof 33